Evidence for Oral Probiotics Such as BioGaia (Lactobacillus reuteri)
The evidence for oral probiotics like BioGaia (Lactobacillus reuteri) is condition-specific, with strong evidence supporting their use in antibiotic-associated diarrhea and C. difficile-associated diarrhea, but limited evidence for general health support in healthy individuals. 1, 2
Established Evidence-Based Uses of Probiotics
Gastrointestinal Conditions
- Probiotics show strong evidence of effectiveness for antibiotic-associated diarrhea in both adults and children, with specific strains like Lactobacillus rhamnosus (11 CFU/day) and Saccharomyces boulardii showing particular benefit 1
- Clostridium difficile-associated diarrhea can be prevented with probiotics, reducing risk by up to 64% when given alongside antibiotics 1
- For constipation, Bifidobacterium lactis may improve intestinal transit, evacuation frequency, and stool consistency 1
- In ulcerative colitis, probiotic treatment shows promise as both remission induction and maintenance therapy, though not effective for Crohn's disease 1
Respiratory Infections
- Probiotics are superior to placebo in reducing the number of upper respiratory tract infection episodes, shortening infection duration, reducing antibiotic use, and decreasing school/work absences 1
- However, optimal strains and dosages for respiratory infections remain to be determined 1
Specific Evidence for Lactobacillus reuteri (BioGaia)
- Lactobacillus reuteri may be useful in the short term as an adjunct to non-surgical periodontal treatment of chronic periodontitis, though more research is needed 1
- For infantile colic, L. reuteri is well-evidenced both as a prophylactic measure and as a preferred therapy 3
- L. reuteri can be recommended as an adjuvant strategy for diarrhea, constipation, and Helicobacter pylori infection 3
- For irritable bowel syndrome (IBS), one study found that L. reuteri (BioGaia) increased defecation frequency but was not better than placebo for controlling other IBS symptoms 4
Limited or Insufficient Evidence
- For general health support in healthy individuals, there is insufficient evidence to support unconditional, population-wide recommendations for preventive benefits of probiotics 5
- Evidence is lacking for probiotics in treating liver diseases, vaginosis, urinary tract infections, depression, and pancreatitis 1
- For metabolic diseases (diabetes, dyslipidemia, obesity, hypertension), more well-conducted studies are needed to demonstrate efficacy 1
Strain Specificity and Dosage Considerations
- Probiotic effects are strain-specific, dose-specific, and disease-specific 2, 1
- Claims for medical benefits can only be made for the specific strains in which they have been demonstrated 1
- No single strain would be expected to have all the effects known to derive from probiotics 1
- A probiotic should typically contain several billion microorganisms to increase the chance of adequate gut colonization 6
Safety Considerations
- Probiotics are generally considered safe for infants, children, adults, and older patients 2
- Most common side effects include bloating and flatulence 6
- Caution is advised in immunologically vulnerable populations, critically ill patients, or those with central venous catheters due to rare risk of systemic infections 6
- Bacteria-derived probiotics should be separated from antibiotics by at least two hours 6
Regulatory and Quality Considerations
- The probiotic market is relatively unregulated, with claims often transferred from tested products to those with material differences in formulation or manufacture 1
- This "probiotic umbrella" concept can be problematic, especially for conditions like inflammatory bowel disease or in immunocompromised patients 1
In conclusion, while specific probiotics like Lactobacillus reuteri have demonstrated benefits for certain conditions, their use for general health support requires further research. When considering probiotics, it's important to match the specific strain to the intended health outcome and to recognize that quality and formulation can vary significantly between products.